Patents by Inventor François Jenck

François Jenck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of benzimidazole-proline derivatives
    Patent number: 9914721
    Abstract: The present invention relates to compounds of the formula (I) wherein Ar1 and Ar2 are as described in the description and to their use as pharmaceuticals for the treatment of sundown syndrome. The invention also relates to the preparation of such compounds and of pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: December 3, 2014
    Date of Patent: March 13, 2018
    Assignee: IDORSIA PHARMACEUTICALS LTD
    Inventors: Christoph Boss, Catherine Roch, Christine Brotschi, Markus Gude, Bibia Heidmann, Francois Jenck, Thierry Sifferlen, Michel Steiner, Jodi T. Williams
  • USE OF BENZIMIDAZOLE-PROLINE DERIVATIVES
    Publication number: 20170001985
    Abstract: The present invention relates to compounds of the formula (I), wherein Ar1 and Ar2 are as described in the description and to their use as pharmaceuticals for the treatment of sundown syndrome. The invention also relates to the preparation of such compounds and of pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: December 3, 2014
    Publication date: January 5, 2017
    Inventors: Christoph BOSS, Catherine ROCH, Christine BROTSCHI, Markus GUDE, Bibia HEIDMANN, Francois JENCK, Thierry SIFFERLEN, Michel STEINER, Jodi T. WILLIAMS
  • Tetrahydroquinoline derivatives for treating post-traumatic stress disorders
    Patent number: 9532985
    Abstract: The invention relates to methods of treating, reducing the symptoms of, or preventing a post-traumatic stress syndrome by administration of tetrahydroquinoline derivatives of formula I wherein R1 and R2 each independently represent (C1-C4)alkoxy, R3 represents aryl-(C1-C4)alkyl or heteroaryl-(C1-C4)alkyl, and R4 represents hydrogen or (C1-C4)alkyl, or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: October 9, 2008
    Date of Patent: January 3, 2017
    Assignee: ACTELION PHARMACEUTICALS LTD.
    Inventor: Francois Jenck
  • TETRAHYDROQUINOLINE DERIVATIVES FOR TREATING POST-TRAUMATIC STRESS DISORDERS
    Publication number: 20100234420
    Abstract: The invention relates to methods of treating, reducing the symptoms of, or preventing a post-traumatic stress syndrome by administration of tetrahydroquinoline derivatives of formula I wherein R1 and R2 each independently represent (C1-C4)alkoxy, R3 represents aryl-(C1-C4)alkyl or heteroaryl-(C1-C4)alkyl, and R4 represents hydrogen or (C1-C4)alkyl, or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: October 9, 2008
    Publication date: September 16, 2010
    Inventor: Francois Jenck
  • Tetrahydroisoquinoline Derivatives to Enhance Memory Function
    Publication number: 20090082394
    Abstract: The invention relates to the use of tetrahydroisoquinoline derivatives for the preparation of a medicament to enhance, maintain and/or restore all stages and/or types of short-, middle- and/or long-term memory.
    Type: Application
    Filed: March 14, 2007
    Publication date: March 26, 2009
    Applicant: ACTELION PHARMACEUTICALS, LTD.
    Inventor: Francois Jenck
  • Di-or triaza-spiro [4,5] decane derivatives
    Patent number: 6642247
    Abstract: The present invention relates to compounds of the general formula wherein R1 is C6-10-cycloalkyl, optionally substituted by lower alkyl or —C(O)O-lower alkyl; decahydro-naphthalen-1-yl; decahydro-naphthalen-2-yl; indan-1-yl or indan-2-yl, optionally substituted by lower alkyl; decahydro-azulen-2-yl; bicyclo[6.2.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: November 4, 2003
    Assignee: Hoffman-La Roche Inc.
    Inventors: Geo Adam, Andrea Cesura, François Jenck, Sabine Kolczewski, Stephan Röver, Jürgen Wichmann
  • DI-OR TRIAZA-SPIRO [4,5] DECANE DERIVATIVES
    Publication number: 20030176701
    Abstract: The present invention relates to compounds of the general formula 1
    Type: Application
    Filed: June 11, 1999
    Publication date: September 18, 2003
    Inventors: GEO ADAM, ANDREA CESURA, FRANCOIS JENCK, SABINE KOLCZEWSKI, STEPHAN ROVER, JURGEN WICHMANN
  • Imidazodiazepine derivative
    Patent number: 6391873
    Abstract: The present invention relates to compound 7-Chloro-3-(5-dimethylaminomethyl-[1,2,4]oxadiazol-3-yl)-5-methyl-4,5-dihydro-imidazo[1,5-a][1,4]benzodiazepin-6-one (I) and to the use of the compound of formula I for the manufacture of medicaments to be used as anxiolytic and/or anticonvulsant and/or non-sedative sleep-inducing medicaments.
    Type: Grant
    Filed: May 8, 2000
    Date of Patent: May 21, 2002
    Assignee: Hoffman-La Roche Inc.
    Inventors: François Jenck, Fabienne Hoffmann-Emery, Walter Hunkeler, James Richard Martin, Andrew Sleight
  • Di-or triaza-spiro [4,5] decane derivatives
    Patent number: 6172075
    Abstract: The present invention relates to compounds of the general formula wherein R1 is C6-10-cycloalkyl, optionally substituted by lower alkyl or —C(O)O-lower alkyl; decahydro-naphthalen-1-yl; decahydro-naphthalen-2-yl; indan-1-yl or indan-2-yl, optionally substituted by lower alkyl; decahydro-azulen-2-yl; bicyclo[6.2.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: January 9, 2001
    Assignee: Hoffman-La Roche Inc.
    Inventors: Geo Adam, Andrea Cesura, François Jenck, Sabine Kolczewski, Stephan Röver, J{umlaut over (u)}rgen Wichmann